Head_Type,Head_Entity,Relation,Tail_Type,Tail_Entity,Description
Clinical_Test,CDR,evaluates,Clinical_Stage,progression to dementia,CDR用于评估向痴呆的进展
Clinical_Stage,prodromal AD,has_subtype,Clinical_Manifestation,executive function deficits,前驱期AD患者具有执行功能缺陷的亚型
Imaging_Method,FDG-PET,detects,Pathological_Change,hypometabolism,FDG-PET用于检测脑代谢减退
Clinical_Stage,prodromal AD,has_characteristic,Biomarker,lower Aβ biomarker burden,前驱期AD患者具有较低的Aβ生物标志物负担特征
Pathological_Change,hypometabolism,associated_with,Disease,Alzheimer's disease,脑代谢减退与阿尔茨海默病相关
Clinical_Stage,cortical-predominant subtype,has_symptom,Clinical_Manifestation,executive function impairment,以皮质为主的低代谢亚型表现为执行功能受损
Biomarker,tau,associated_with,Clinical_Stage,prodromal AD,tau生物标志物与前驱期AD相关
Clinical_Stage,no hypometabolism subtype,has_risk,Risk_Factor,lower Aβ burden,无低代谢亚型伴随较低的Aβ负担
Brain_Region,hippocampus,affected_by,Pathological_Change,atrophy,海马体受到萎缩的影响
Disease,Alzheimer's disease,has_subtype,Clinical_Stage,prodromal AD,阿尔茨海默病有前驱期亚型
Clinical_Stage,no hypometabolism subtype,has_risk,Risk_Factor,lower risk of progression to dementia,无低代谢亚型进展为痴呆的风险较低
Disease,Alzheimer's disease,has_biomarker,Biomarker,amyloid-beta,阿尔茨海默病的生物标志物包括淀粉样蛋白
Biomarker,APOE ε4,increases_risk_of,Disease,Alzheimer's disease,APOE ε4基因是阿尔茨海默病的风险因素
Clinical_Test,FDG-PET,detects,Pathological_Change,hypometabolism,FDG-PET用于检测低代谢的病理变化
Imaging_Method,FDG-PET,detects,Pathological_Change,hypometabolism,FDG-PET检测到代谢减退的病理改变
Disease,Alzheimer's disease,has_subtype,Clinical_Stage,cortical-predominant subtype,阿尔茨海默病具有以皮质为主的低代谢亚型
Clinical_Stage,no hypometabolism subtype,has_biomarker,Biomarker,higher hippocampal and cortical volumes,无低代谢亚型伴随较高的海马和皮质体积
Clinical_Stage,prodromal AD,has_characteristic,Biomarker,concomitant tau biomarker positivity,前驱期AD患者具有伴随tau生物标志物阳性的特征
Clinical_Stage,typical subtype,has_symptom,Clinical_Manifestation,faster decline in executive function,典型的低代谢亚型表现为执行功能更快下降
Clinical_Stage,limbic-predominant subtype,has_symptom,Clinical_Manifestation,memory function decline,边缘系统为主的低代谢亚型表现为记忆功能下降
Imaging_Method,MRI,detects,Pathological_Change,brain atrophy,MRI用于检测脑萎缩
Protein,tau,accumulates_in,Brain_Region,brain,tau蛋白在大脑中异常堆积
Clinical_Test,AV45-PET,measures,Biomarker,amyloid-beta,AV45-PET用于测量淀粉样蛋白水平
Research_Method,hierarchical clustering,classifies,Clinical_Stage,AD dementia,层次聚类方法用于分类AD痴呆亚型
Clinical_Test,FDG-PET,classifies,Clinical_Stage,prodromal AD,FDG-PET用于分类前驱期AD亚型
Clinical_Test,MMSE,evaluates,Clinical_Manifestation,cognitive function,MMSE用于评估认知功能
Clinical_Stage,prodromal AD,has_characteristic,Clinical_Manifestation,cognitive impairment,前驱期AD患者具有认知功能障碍特征
Protein,amyloid-beta,accumulates_in,Brain_Region,brain,淀粉样蛋白在大脑中异常堆积
Clinical_Stage,limbic-predominant subtype,has_biomarker,Biomarker,hippocampal volume reduction,边缘系统为主的低代谢亚型伴随海马体积减少
Clinical_Stage,cortical-predominant subtype,affects,Brain_Region,frontal lobe,以皮质为主的低代谢亚型主要影响额叶
Gene,APOE ε4,increases_risk_of,Disease,Alzheimer's disease,APOE ε4基因增加阿尔茨海默病风险
Clinical_Stage,limbic-predominant subtype,affects,Brain_Region,medial temporal lobe,边缘系统为主的低代谢亚型主要影响内侧颞叶
Clinical_Stage,prodromal AD,has_subtype,Clinical_Manifestation,memory-selective cognitive decline,前驱期AD患者具有记忆选择性认知下降的亚型
Clinical_Stage,prodromal AD,has_characteristic,Biomarker,Aβ biomarker burden,前驱期AD患者具有Aβ生物标志物负担特征
Clinical_Stage,prodromal AD,has_subtype,Clinical_Manifestation,cortical-predominant cognitive decline,前驱期AD患者具有皮质主导的认知下降亚型
Clinical_Stage,prodromal AD,has_characteristic,Risk_Factor,progression to dementia,前驱期AD患者具有进展为痴呆的风险
Clinical_Manifestation,executive dysfunction,associated_with,Disease,Alzheimer's disease,执行功能障碍与阿尔茨海默病相关
Clinical_Stage,typical subtype,affects,Brain_Region,posterior temporo-parietal areas,典型的低代谢亚型主要影响后颞顶叶区域
Research_Method,hierarchical clustering,classifies,Disease,Alzheimer's disease,层次聚类用于分类阿尔茨海默病亚型
Clinical_Stage,limbic-predominant subtype,has_symptom,Clinical_Manifestation,memory-predominant cognitive profile,边缘系统为主的低代谢亚型表现为以记忆为主的认知特征
Disease,Alzheimer's disease,has_biomarker,Biomarker,tau,阿尔茨海默病的生物标志物包括tau蛋白
Clinical_Test,CSF analysis,measures,Biomarker,tau,脑脊液分析用于测量tau蛋白水平
Disease,Alzheimer's disease,has_subtype,Clinical_Stage,AD dementia,阿尔茨海默病有痴呆期亚型
Disease,Alzheimer's disease,has_subtype,Clinical_Stage,typical subtype,阿尔茨海默病具有典型的后颞顶叶低代谢亚型
Clinical_Test,MRI,classifies,Clinical_Stage,AD dementia,MRI用于分类AD痴呆亚型
Pathological_Change,neurofibrillary tangle,associated_with,Disease,Alzheimer's disease,神经原纤维缠结与阿尔茨海默病相关
Clinical_Stage,limbic-predominant subtype,has_risk,Risk_Factor,older age,边缘系统为主的低代谢亚型与较高年龄相关
Brain_Region,hippocampus,affected_by,Disease,Alzheimer's disease,阿尔茨海默病影响海马体
Clinical_Stage,prodromal AD,has_subtype,Clinical_Manifestation,typical cognitive decline,前驱期AD患者具有典型认知下降亚型
Risk_Factor,small vessel vascular disease,associated_with,Disease,Alzheimer's disease,小血管疾病是阿尔茨海默病的风险因素
Clinical_Stage,prodromal AD,has_subtype,Clinical_Manifestation,limbic-predominant cognitive decline,前驱期AD患者具有边缘系统主导的认知下降亚型
Disease,Alzheimer's disease,has_subtype,Clinical_Stage,limbic-predominant subtype,阿尔茨海默病具有以边缘系统为主的低代谢亚型
Clinical_Stage,cortical-predominant subtype,has_biomarker,Biomarker,higher HV:CTV ratio,以皮质为主的低代谢亚型伴随较高的海马与皮质体积比
Clinical_Stage,prodromal AD,has_characteristic,Clinical_Manifestation,minimal hypometabolism,前驱期AD患者具有轻微代谢减退的特征
Clinical_Manifestation,memory loss,associated_with,Disease,Alzheimer's disease,记忆力丧失与阿尔茨海默病相关
Clinical_Stage,cortical-predominant subtype,has_symptom,Clinical_Manifestation,executive function over memory deficit,以皮质为主的低代谢亚型表现为执行功能相对于记忆功能的更显著缺陷
Imaging_Method,MRI,detects,Pathological_Change,brain atrophy,MRI检测到脑萎缩的病理改变
Clinical_Stage,cortical-predominant subtype,has_risk,Risk_Factor,lower APOE ε4 carrier rate,以皮质为主的低代谢亚型伴随较低的APOE ε4携带率
Brain_Region,cortex,affected_by,Disease,Alzheimer's disease,阿尔茨海默病影响大脑皮层
Risk_Factor,old age,associated_with,Disease,Alzheimer's disease,高龄是阿尔茨海默病的风险因素
